Overview
Jean-pierre Bourquin practices in Zurich, Switzerland. Mr. Bourquin is rated as an Elite expert by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult T-Cell Leukemia, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.
His clinical research consists of co-authoring 117 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 73 articles in the study of Acute Lymphoblastic Leukemia (ALL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Lymphoblastic Leukemia (ALL)
- Distinguished
- LeukemiaMr. Bourquin isDistinguished. Learn about Leukemia.
- Advanced
- Adult T-Cell LeukemiaMr. Bourquin isAdvanced. Learn about Adult T-Cell Leukemia.
- Experienced
- Acute Erythroid Leukemia (AEL)Mr. Bourquin isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Myeloid Leukemia (AML)Mr. Bourquin isExperienced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaMr. Bourquin isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMr. Bourquin isExperienced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaMr. Bourquin isExperienced. Learn about Burkitt Lymphoma.
- Childhood Acute Myeloid LeukemiaMr. Bourquin isExperienced. Learn about Childhood Acute Myeloid Leukemia.